Skip to content

Trial Summary

An International, Multicenter, Open-label, Randomized, Phase 3 Study of Avapritinib vs Sunitinib in Patients with Genomically Selected Gastrointestinal Stromal Tumor (GIST).

Acronym:

BLU-285-1304

ACTRN/NCT /ethics:

Scientific title:

An International, Multicenter, Open-label, Randomized, Phase 3 Study of Avapritinib vs Sunitinib in Patients with Genomically Selected Gastrointestinal Stromal Tumor (GIST)

Sponsor / Cooperative group:

Trial & Patient Characteristics

Cancer TypeBowel and Colon, Stomach & Oesophageal
Trial TypeTreatment
PhasePhase III
Age Range18 years and older
SexBoth
Tumour Stream -
Cancer StageAll stages
Anticipated Start Date-
Anticipated End Date-

Participating Hospitals

HospitalFlinders Medical Centre
Clinical Trial CoordinatorAlex Scott-Hoy
Emailalex.scott-hoy@sa.gov.au
Phone08 8204 4830
Principal InvestigatorDr Amitesh Roy
Recruitment StatusNot Yet Recruiting